You searched for "products"
Optimising hearing aid processing for music appreciation
Hearing aid manufacturers’ main focus has, up until recently, been improvement of speech intelligibility. Today’s hearing aid users have much broader demands however and often cite improved music perception as a key outcome or goal. Drs Tish Ramirez and Rebecca...The effects of leisure noise exposure on young people’s hearing
There is growing concern regarding the effects of leisure noise exposure on young people’s auditory system. Information provided by healthcare professionals should be evidence-based; Hannah Keppler discusses some recent findings about hearing in young people. Excessive noise exposure can lead...The evolving role of OAEs in newborn hearing screening
An admission on emissions from James Hall! OAEs hold an established place in the screening of infants; Professor Hall introduces how OAEs established this position and the advances keeping the test relevant to today’s infant screening battery. Introduction Truthfully, when...Cocaine-induced ENT pseudo-GPA (CIEpGPA): an underdiagnosed entity
Cocaine-induced ENT pseudo-GPA is increasingly seen in our ENT clinics. The authors of a new ENT UK guideline offer a concise overview for day-to-day recognition and management. Use of cocaine has steadily increased in Europe since 2010 and now represents...BLA Presidency transfers from Mark Watson to Guri Sandhu
The BLA welcomed Guri Sandhu as incoming President from 1 May 2021. Guri Sandhu is a founding member of the BLA and current President of the Laryngology & Rhinology section at the RSM. He is a Consultant Otolaryngologist and Head...EUHA: the countdown is on
The 66th International Congress of Hearing Aid Acousticians and the accompanying Industry Exhibition will open on 12 October 2022, providing insights into innovations in the field of hearing.
Is Dymista® useful for paediatric allergic rhinitis?
Allergic rhinitis (AR) affects up to 14.6% of the paediatric population. Whilst a recent Cochrane review has considered the evidence for intranasal corticosteroids as `weak and unreliable’ in paediatric AR, this product is a novel formulation combining Fluticasone and Azelastine...
